Semaglutide is a medication intended to stimulate GLP-1 receptors which lowers the blood sugar levels for those suffering from type 2 diabetes. It was approved by the FDA in 2017 as it also assists the body to push insulin levels up and suppress the appetite. In 2021, it also got approval for treating obesity as it helps in effective weight loss and se purely marketed as ‘Wegovy’. Semaglutide has proven to be effective particularly in weight reduction and diabetes management as such it is a useful drug for these disease conditions.
Tirzepatide is an innovative drug designed to deal with type 2 diabetes and obesity using GLP-1 and GIP as target hormones. Its effectiveness relies on the innovative mechanism of action dual receptor action improves appetite and insulin resistance as well as blood glucose levels, making it a good candidate for management of metabolic disorders. As it is branded Mounjaro and used off label is increasing due to positive results in achieving better glycemic control and better weight loss hence it is an adjunctive drug in a broader spectrum of hormone health improvement programs.
By incorporating longevity-focused healthcare into your practice, you’re not just treating symptoms; you’re addressing the root cause of countless health concerns. From hormone replacement therapy to personalized wellness plans and beyond, you have the opportunity to make a transformative difference in your patients’ lives.
Join us in revolutionizing healthcare, one step at a time. Together, let’s empower our patients to reclaim their vitality and thrive. Contact us today to discover how you can elevate your practice with Longevity Health Plans. Your patients deserve nothing less.
Sign up and join us in healthcare revolution!